Allscripts Healthcare Solutions (NASDAQ:MDRX) Downgraded by TheStreet to “D+”

TheStreet cut shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) from a c- rating to a d+ rating in a research note published on Tuesday morning, TheStreetRatingsTable reports.

Several other research analysts have also recently issued reports on MDRX. ValuEngine cut Allscripts Healthcare Solutions from a hold rating to a sell rating in a research note on Friday, July 26th. Robert W. Baird set a $13.00 price objective on Allscripts Healthcare Solutions and gave the stock a buy rating in a research note on Monday. Evercore ISI reissued a hold rating and issued a $11.50 price objective on shares of Allscripts Healthcare Solutions in a research note on Sunday. Cantor Fitzgerald reissued a hold rating and issued a $10.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Thursday, May 2nd. Finally, Zacks Investment Research raised Allscripts Healthcare Solutions from a sell rating to a hold rating in a research note on Wednesday, April 24th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $12.25.

Shares of MDRX traded down $0.03 during mid-day trading on Tuesday, reaching $8.97. 26,263 shares of the company’s stock traded hands, compared to its average volume of 2,252,891. The stock has a market capitalization of $1.49 billion, a PE ratio of 16.13, a P/E/G ratio of 1.96 and a beta of 1.30. The firm’s 50-day moving average is $10.80. Allscripts Healthcare Solutions has a 12 month low of $8.54 and a 12 month high of $14.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.04 and a current ratio of 1.04.



Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, August 8th. The software maker reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. The firm had revenue of $444.50 million for the quarter, compared to analysts’ expectations of $449.03 million. Allscripts Healthcare Solutions had a return on equity of 6.10% and a net margin of 9.85%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.18 earnings per share. As a group, equities research analysts forecast that Allscripts Healthcare Solutions will post 0.48 EPS for the current year.

Several institutional investors and hedge funds have recently modified their holdings of the company. Nomura Asset Management Co. Ltd. purchased a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter valued at approximately $26,000. Parallel Advisors LLC acquired a new position in Allscripts Healthcare Solutions in the second quarter valued at $28,000. C M Bidwell & Associates Ltd. purchased a new stake in shares of Allscripts Healthcare Solutions in the second quarter valued at about $34,000. Sun Life Financial INC purchased a new position in Allscripts Healthcare Solutions during the second quarter worth about $41,000. Finally, Quantamental Technologies LLC acquired a new position in Allscripts Healthcare Solutions during the second quarter worth about $57,000.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Featured Article: Can systematic risk be avoided?

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.